Hypera SA (HYPMY)
4.35
-0.46
(-9.56%)
USD |
OTCM |
Jan 20, 15:58
Hypera Market Cap: 2.753B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Raia Drogasil SA | 8.384B |
| CEL-SCI Corp. | 16.30M |
| AIM ImmunoTech, Inc. | 3.456M |
| IGC Pharma, Inc. | 26.02M |
| NovaBay Pharmaceuticals, Inc. | 825.37M |
Market Cap Related Metrics
| PE Ratio | 18.65 |
| PS Ratio | 2.252 |
| Price to Book Value | 1.197 |
| Price to Free Cash Flow | 25.76 |
| Price | 4.35 |
| Earnings Yield | 5.36% |
| Operating PE Ratio | 13.38 |
| Normalized PE Ratio | 19.44 |